Hologic (Hologic) ROE % Adjusted to Book Value : 5.66% (As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Hologic ROE % Adjusted to Book Value?

Hologic's ROE % for the quarter that ended in Dec. 2023 was 20.39%. Hologic's PB Ratio for the quarter that ended in Dec. 2023 was 3.60. Hologic's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 5.66%.

Hologic ROE % Adjusted to Book Value Historical Data

The historical data trend for Hologic's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic ROE % Adjusted to Book Value Chart

Hologic Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-1.40

7.31

12.18

8.76

2.76

Hologic Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															4.15	4.49	-0.81	2.13	5.66

Competitive Comparison of Hologic's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Hologic's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hologic's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hologic's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hologic's ROE % Adjusted to Book Value falls into.

Hologic ROE % Adjusted to Book Value Calculation

Hologic's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.22%	/	3.34
	=	2.76%

Hologic's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	20.39%	/	3.60
	=	5.66%

Hologic ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Hologic's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Hologic (Hologic) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (NAS:HOLX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

HOLX:Mexico HO1:Germany HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Executives

Charles J Dockendorff	director	COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Scott T Garrett	director	35 CROSBY DRIVE, BEDFORD MA 01730
Stephen P Macmillan	director, officer: President and CEO	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Essex D Mitchell	officer: Div. President, GYN Surgical	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Nanaz Mohtashami	director	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Jennifer M Schneiders	officer: President, Diag. Solutions	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Benjamin Jordan Cohn	officer: Principal Accounting Officer	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Stacey D. Stewart	director	5920 WALHONDING ROAD, BETHESDA MD 20816
Elisabeth A Hellmann	officer: SVP, Human Resources	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Kevin R Thornal	officer: Div. President, Diagnostics	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
John M. Griffin	officer: General Counsel	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Karleen Marie Oberton	officer: Corp. VP, Finance & Acconting	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Erik S Anderson	officer: Div. Pres., Breast & Skeletal	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Jan Verstreken	officer: Group President, International	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Allison P Bebo	officer: SVP, Human Resources	250 CAMPUS DRIVE, MARLBOROUGH MA 01752